BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11536038)

  • 1. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
    Yin M; Hapke G; Guo B; Azrak RG; Frank C; Rustum YM
    Oncogene; 2001 Aug; 20(38):5249-57. PubMed ID: 11536038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350.
    Yin MB; Hapke G; Wu J; Azrak RG; Frank C; Wrzosek C; Rustum YM
    Biochem Biophys Res Commun; 2002 Jul; 295(2):435-44. PubMed ID: 12150968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350.
    Yin MB; Guo B; Vanhoefer U; Azrak RG; Minderman H; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Mol Pharmacol; 2000 Mar; 57(3):453-9. PubMed ID: 10692484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
    Hapke G; Yin MB; Wu J; Frank C; Rustum YM
    Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
    Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
    Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
    Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
    Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
    Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
    Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
    Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
    Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
    Hsu SC; Yu CC; Yang JS; Lai KC; Wu SH; Lin JJ; Kuo JH; Yang ST; Huang CC; Kuo SC; Chung JG
    Int J Oncol; 2012 Mar; 40(3):731-8. PubMed ID: 22021033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Kim BK; Lee YY
    Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.
    Jin ZH; Kurosu T; Yamaguchi M; Arai A; Miura O
    Oncogene; 2005 Mar; 24(12):1973-81. PubMed ID: 15674326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.
    Yan Y; Black CP; Cowan KH
    Oncogene; 2007 Jul; 26(32):4689-98. PubMed ID: 17297454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
    Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
    Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells.
    Shao RG; Cao CX; Pommier Y
    Acta Pharmacol Sin; 2004 Jun; 25(6):756-62. PubMed ID: 15169628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
    Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
    J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells.
    Liao WL; Lin JY; Shieh JC; Yeh HF; Hsieh YH; Cheng YC; Lee HJ; Shen CY; Cheng CW
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.